3 terminated, 2 completed, 1 active not recruiting. 5 Phase 1, 1 Early Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Terminated 3, Active not recruiting 1, Completed 1 |
| Early Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow Bexion Pharmaceuticals, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| BXQ-350 in Newly Diagnosed Metastatic Colorectal Carcinoma BXQ-350, Placebo - Metastatic Colorectal Carcinoma, Neuropathy | Phase 1 / Phase 2 | Active not recruiting | Bexion Pharmaceuticals, Inc. | 195 | 2023-01-09 | 2026-09-29 |
| BXQ-350 Pharmacokinetic/Pharmacodynamic Study in Cancer Patients BXQ-350, Placebo - Neuropathy;Peripheral, Chemotherapy-induced Peripheral Neuropathy | Early Phase 1 | Completed | Bexion Pharmaceuticals, Inc. | 21 | 2022-10-17 | 2025-01-27 |
| A Study of BXQ-350 in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG) or Diffuse Midline Glioma (DMG) BXQ-350 - Part 1 Dose Escalation: Safety and Tolerance, BXQ-350 - Part 2 BXQ-350 Tumor and Plasma Concentrations - Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, H3 K27M-Mutant | Phase 1 | Terminated | Bexion Pharmaceuticals, Inc. | 10 | 2021-05-24 | 2024-12-20 |
| Continued Treatment for Participants Enrolled in Studies of BXQ-350 BXQ-350 - Neoplasms | Phase 1 | Terminated | Bexion Pharmaceuticals, Inc. | 5 | 2020-06-08 | 2024-12-20 |
| A Study of BXQ-350 in Children and Young Adults With Relapsed Solid Tumors BXQ-350 - Neoplasms | Phase 1 | Terminated | Bexion Pharmaceuticals, Inc. | 9 | 2019-04-15 | 2021-07-22 |
| Phase 1 Study of BXQ-350 in Adult Patients With Advanced Solid Tumors BXQ-350 - Neoplasms | Phase 1 | Completed | Bexion Pharmaceuticals, Inc. | 86 | 2016-09-01 | 2021-07-22 |
Neoplasms (3) · Brain Neoplasms (2) · Ependymoma (2) · Glioblastoma (2) · Glioma (2) · Colorectal Neoplasms (1) · Diffuse Intrinsic Pontine Glioma (1) · Neuritis (1)
Drug Tolerance (1)
United States (6)